APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Clinical Endpoint Assessment Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Clinical Endpoint Assessment Software Market Analysis and Forecast 2026-2032

12 August 2026191 pages

Choose your research edition.

Industry ResearchAI Clinical Endpoint Assessment Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Clinical Endpoint Assessment Software Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal AI Clinical Endpoint Assessment Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Clinical Endpoint Assessment Software Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Clinical Endpoint Assessment Software Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global AI Clinical Endpoint Assessment Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Clinical Endpoint Assessment Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Clinical Endpoint Assessment Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Clinical Endpoint Assessment Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Clinical Endpoint Assessment Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Clinical Endpoint Assessment Software include IQVIA, ICON, Perceptive, Clinical Ink, Koneksa, AiCure, Medable, PathAI and Proscia, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Clinical Endpoint Assessment Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Clinical Endpoint Assessment Software, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Clinical Endpoint Assessment Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Clinical Endpoint Assessment Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Clinical Endpoint Assessment Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Clinical Endpoint Assessment Software revenue, projected growth trends, production technology, application and end-user industry.

AI Clinical Endpoint Assessment Software Segment by Company

IQVIA

ICON

Perceptive

Clinical Ink

Koneksa

AiCure

Medable

PathAI

Proscia

Paige

IXICO

Median Technologies

VIDA Diagnostics

Image Analysis Group

QMENTA

Cambridge Cognition

Cogstate

Empatica

Cumulus Neuroscience

Rune Labs

VivoSense

NeuraLight

Aural Analytics

Linus Health

Quibim

Perspectum

Brainomix

Taimei Technology

UnionClin

XincereMed

Clario

Medidata

Signant Health

AI Clinical Endpoint Assessment Software Segment by Type

Medical Imaging Endpoints

Digital Pathology Endpoints

Electronic Clinical Outcome Assessment

Wearable and Physiological Endpoints

Voice, Video and Cognitive Endpoints

Multimodal Endpoints

AI Clinical Endpoint Assessment Software Segment by Application

Oncology

Neurology and Psychiatry

Cardiovascular and Metabolic Diseases

Respiratory Diseases

Musculoskeletal and Immunology

Other Therapeutic Areas

AI Clinical Endpoint Assessment Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Endpoint Assessment Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Endpoint Assessment Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Endpoint Assessment Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Clinical Endpoint Assessment Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Clinical Endpoint Assessment Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Clinical Endpoint Assessment Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Medical Imaging Endpoints Major Player Table 3. Digital Pathology Endpoints Major Player Table 4. Electronic Clinical Outcome Assessment Major Player Table 5. Wearable and Physiological Endpoints Major Player Table 6. Voice, Video and Cognitive Endpoints Major Player Table 7. Multimodal Endpoints Major Player Table 8. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Oncology Major Player Table 10. Neurology and Psychiatry Major Player Table 11. Cardiovascular and Metabolic Diseases Major Player Table 12. Respiratory Diseases Major Player Table 13. Musculoskeletal and Immunology Major Player Table 14. Other Therapeutic Areas Major Player Table 15. AI Clinical Endpoint Assessment Software Industry Trends Table 16. AI Clinical Endpoint Assessment Software Industry Drivers Table 17. AI Clinical Endpoint Assessment Software Industry Opportunities and Challenges Table 18. AI Clinical Endpoint Assessment Software Industry Restraints Table 19. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 20. Global AI Clinical Endpoint Assessment Software Market Size by Region (2021-2026) & (US$ Million) Table 21. Global AI Clinical Endpoint Assessment Software Market Share by Region (2021-2026) Table 22. Global AI Clinical Endpoint Assessment Software Market Size by Region (2027-2032) & (US$ Million) Table 23. Global AI Clinical Endpoint Assessment Software Market Share by Region (2027-2032) Table 24. Global AI Clinical Endpoint Assessment Software Revenue by Players (US$ Million) & (2021-2026) Table 25. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Players (2021-2026) Table 26. Global AI Clinical Endpoint Assessment Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 27. Global AI Clinical Endpoint Assessment Software Key Players Headquarters & Area Served Table 28. Global AI Clinical Endpoint Assessment Software Players, Product Type & Application Table 29. Global AI Clinical Endpoint Assessment Software Players Establishment Date Table 30. Global Players Market Concentration Ratio (CR5 and HHI) Table 31. Global AI Clinical Endpoint Assessment Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global AI Clinical Endpoint Assessment Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AI Clinical Endpoint Assessment Software Revenue by Type (2021-2026) & (US$ Million) Table 34. Global AI Clinical Endpoint Assessment Software Revenue by Type (2027-2032) & (US$ Million) Table 35. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Type (2021-2026) Table 36. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Type (2027-2032) Table 37. Global AI Clinical Endpoint Assessment Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global AI Clinical Endpoint Assessment Software Revenue by Application (2021-2026) & (US$ Million) Table 39. Global AI Clinical Endpoint Assessment Software Revenue by Application (2027-2032) & (US$ Million) Table 40. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2021-2026) Table 41. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2027-2032) Table 42. IQVIA Company Information Table 43. IQVIA Business Overview Table 44. IQVIA AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. IQVIA AI Clinical Endpoint Assessment Software Product Portfolio Table 46. IQVIA Recent Development Table 47. ICON Company Information Table 48. ICON Business Overview Table 49. ICON AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. ICON AI Clinical Endpoint Assessment Software Product Portfolio Table 51. ICON Recent Development Table 52. Perceptive Company Information Table 53. Perceptive Business Overview Table 54. Perceptive AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Perceptive AI Clinical Endpoint Assessment Software Product Portfolio Table 56. Perceptive Recent Development Table 57. Clinical Ink Company Information Table 58. Clinical Ink Business Overview Table 59. Clinical Ink AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Clinical Ink AI Clinical Endpoint Assessment Software Product Portfolio Table 61. Clinical Ink Recent Development Table 62. Koneksa Company Information Table 63. Koneksa Business Overview Table 64. Koneksa AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Koneksa AI Clinical Endpoint Assessment Software Product Portfolio Table 66. Koneksa Recent Development Table 67. AiCure Company Information Table 68. AiCure Business Overview Table 69. AiCure AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. AiCure AI Clinical Endpoint Assessment Software Product Portfolio Table 71. AiCure Recent Development Table 72. Medable Company Information Table 73. Medable Business Overview Table 74. Medable AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Medable AI Clinical Endpoint Assessment Software Product Portfolio Table 76. Medable Recent Development Table 77. PathAI Company Information Table 78. PathAI Business Overview Table 79. PathAI AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. PathAI AI Clinical Endpoint Assessment Software Product Portfolio Table 81. PathAI Recent Development Table 82. Proscia Company Information Table 83. Proscia Business Overview Table 84. Proscia AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Proscia AI Clinical Endpoint Assessment Software Product Portfolio Table 86. Proscia Recent Development Table 87. Paige Company Information Table 88. Paige Business Overview Table 89. Paige AI Clinical Endpoint Assessment Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Paige AI Clinical Endpoint Assessment Software Product Portfolio Table 91. Paige Recent Development Table 92. IXICO Company Information Table 93. IXICO Business Overview Table 94. IXICO AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. IXICO AI Clinical Endpoint Assessment Software Product Portfolio Table 96. IXICO Recent Development Table 97. Median Technologies Company Information Table 98. Median Technologies Business Overview Table 99. Median Technologies AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Median Technologies AI Clinical Endpoint Assessment Software Product Portfolio Table 101. Median Technologies Recent Development Table 102. VIDA Diagnostics Company Information Table 103. VIDA Diagnostics Business Overview Table 104. VIDA Diagnostics AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. VIDA Diagnostics AI Clinical Endpoint Assessment Software Product Portfolio Table 106. VIDA Diagnostics Recent Development Table 107. Image Analysis Group Company Information Table 108. Image Analysis Group Business Overview Table 109. Image Analysis Group AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Image Analysis Group AI Clinical Endpoint Assessment Software Product Portfolio Table 111. Image Analysis Group Recent Development Table 112. QMENTA Company Information Table 113. QMENTA Business Overview Table 114. QMENTA AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. QMENTA AI Clinical Endpoint Assessment Software Product Portfolio Table 116. QMENTA Recent Development Table 117. Cambridge Cognition Company Information Table 118. Cambridge Cognition Business Overview Table 119. Cambridge Cognition AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Cambridge Cognition AI Clinical Endpoint Assessment Software Product Portfolio Table 121. Cambridge Cognition Recent Development Table 122. Cogstate Company Information Table 123. Cogstate Business Overview Table 124. Cogstate AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Cogstate AI Clinical Endpoint Assessment Software Product Portfolio Table 126. Cogstate Recent Development Table 127. Empatica Company Information Table 128. Empatica Business Overview Table 129. Empatica AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Empatica AI Clinical Endpoint Assessment Software Product Portfolio Table 131. Empatica Recent Development Table 132. Cumulus Neuroscience Company Information Table 133. Cumulus Neuroscience Business Overview Table 134. Cumulus Neuroscience AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Cumulus Neuroscience AI Clinical Endpoint Assessment Software Product Portfolio Table 136. Cumulus Neuroscience Recent Development Table 137. Rune Labs Company Information Table 138. Rune Labs Business Overview Table 139. Rune Labs AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Rune Labs AI Clinical Endpoint Assessment Software Product Portfolio Table 141. Rune Labs Recent Development Table 142. VivoSense Company Information Table 143. VivoSense Business Overview Table 144. VivoSense AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. VivoSense AI Clinical Endpoint Assessment Software Product Portfolio Table 146. VivoSense Recent Development Table 147. NeuraLight Company Information Table 148. NeuraLight Business Overview Table 149. NeuraLight AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. NeuraLight AI Clinical Endpoint Assessment Software Product Portfolio Table 151. NeuraLight Recent Development Table 152. Aural Analytics Company Information Table 153. Aural Analytics Business Overview Table 154. Aural Analytics AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Aural Analytics AI Clinical Endpoint Assessment Software Product Portfolio Table 156. Aural Analytics Recent Development Table 157. Linus Health Company Information Table 158. Linus Health Business Overview Table 159. Linus Health AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Linus Health AI Clinical Endpoint Assessment Software Product Portfolio Table 161. Linus Health Recent Development Table 162. Quibim Company Information Table 163. Quibim Business Overview Table 164. Quibim AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Quibim AI Clinical Endpoint Assessment Software Product Portfolio Table 166. Quibim Recent Development Table 167. Perspectum Company Information Table 168. Perspectum Business Overview Table 169. Perspectum AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Perspectum AI Clinical Endpoint Assessment Software Product Portfolio Table 171. Perspectum Recent Development Table 172. Brainomix Company Information Table 173. Brainomix Business Overview Table 174. Brainomix AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. Brainomix AI Clinical Endpoint Assessment Software Product Portfolio Table 176. Brainomix Recent Development Table 177. Taimei Technology Company Information Table 178. Taimei Technology Business Overview Table 179. Taimei Technology AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. Taimei Technology AI Clinical Endpoint Assessment Software Product Portfolio Table 181. Taimei Technology Recent Development Table 182. UnionClin Company Information Table 183. UnionClin Business Overview Table 184. UnionClin AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 185. UnionClin AI Clinical Endpoint Assessment Software Product Portfolio Table 186. UnionClin Recent Development Table 187. XincereMed Company Information Table 188. XincereMed Business Overview Table 189. XincereMed AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 190. XincereMed AI Clinical Endpoint Assessment Software Product Portfolio Table 191. XincereMed Recent Development Table 192. Clario Company Information Table 193. Clario Business Overview Table 194. Clario AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 195. Clario AI Clinical Endpoint Assessment Software Product Portfolio Table 196. Clario Recent Development Table 197. Medidata Company Information Table 198. Medidata Business Overview Table 199. Medidata AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 200. Medidata AI Clinical Endpoint Assessment Software Product Portfolio Table 201. Medidata Recent Development Table 202. Signant Health Company Information Table 203. Signant Health Business Overview Table 204. Signant Health AI Clinical Endpoint Assessment Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 205. Signant Health AI Clinical Endpoint Assessment Software Product Portfolio Table 206. Signant Health Recent Development Table 207. North America AI Clinical Endpoint Assessment Software Revenue by Type (2021-2026) & (US$ Million) Table 208. North America AI Clinical Endpoint Assessment Software Revenue by Type (2027-2032) & (US$ Million) Table 209. North America AI Clinical Endpoint Assessment Software Revenue by Application (2021-2026) & (US$ Million) Table 210. North America AI Clinical Endpoint Assessment Software Revenue by Application (2027-2032) & (US$ Million) Table 211. North America AI Clinical Endpoint Assessment Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. North America AI Clinical Endpoint Assessment Software Revenue by Country (2021-2026) & (US$ Million) Table 213. North America AI Clinical Endpoint Assessment Software Revenue by Country (US$ Million) & (2027-2032) Table 214. Europe AI Clinical Endpoint Assessment Software Revenue by Type (2021-2026) & (US$ Million) Table 215. Europe AI Clinical Endpoint Assessment Software Revenue by Type (2027-2032) & (US$ Million) Table 216. Europe AI Clinical Endpoint Assessment Software Revenue by Application (2021-2026) & (US$ Million) Table 217. Europe AI Clinical Endpoint Assessment Software Revenue by Application (2027-2032) & (US$ Million) Table 218. Europe AI Clinical Endpoint Assessment Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. Europe AI Clinical Endpoint Assessment Software Revenue by Country (2021-2026) & (US$ Million) Table 220. Europe AI Clinical Endpoint Assessment Software Revenue by Country (US$ Million) & (2027-2032) Table 221. China AI Clinical Endpoint Assessment Software Revenue by Type (2021-2026) & (US$ Million) Table 222. China AI Clinical Endpoint Assessment Software Revenue by Type (2027-2032) & (US$ Million) Table 223. China AI Clinical Endpoint Assessment Software Revenue by Application (2021-2026) & (US$ Million) Table 224. China AI Clinical Endpoint Assessment Software Revenue by Application (2027-2032) & (US$ Million) Table 225. Asia AI Clinical Endpoint Assessment Software Revenue by Type (2021-2026) & (US$ Million) Table 226. Asia AI Clinical Endpoint Assessment Software Revenue by Type (2027-2032) & (US$ Million) Table 227. Asia AI Clinical Endpoint Assessment Software Revenue by Application (2021-2026) & (US$ Million) Table 228. Asia AI Clinical Endpoint Assessment Software Revenue by Application (2027-2032) & (US$ Million) Table 229. Asia AI Clinical Endpoint Assessment Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 230. Asia AI Clinical Endpoint Assessment Software Revenue by Region (US$ Million) & (2021-2026) Table 231. Asia AI Clinical Endpoint Assessment Software Revenue by Region (US$ Million) & (2027-2032) Table 232. SAMEA AI Clinical Endpoint Assessment Software Revenue by Type (2021-2026) & (US$ Million) Table 233. SAMEA AI Clinical Endpoint Assessment Software Revenue by Type (2027-2032) & (US$ Million) Table 234. SAMEA AI Clinical Endpoint Assessment Software Revenue by Application (2021-2026) & (US$ Million) Table 235. SAMEA AI Clinical Endpoint Assessment Software Revenue by Application (2027-2032) & (US$ Million) Table 236. SAMEA AI Clinical Endpoint Assessment Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 237. SAMEA AI Clinical Endpoint Assessment Software Revenue by Country (2021-2026) & (US$ Million) Table 238. SAMEA AI Clinical Endpoint Assessment Software Revenue by Country (US$ Million) & (2027-2032) Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. AI Clinical Endpoint Assessment Software Image Figure 2. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Clinical Endpoint Assessment Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Medical Imaging Endpoints Image Figure 5. Digital Pathology Endpoints Image Figure 6. Electronic Clinical Outcome Assessment Image Figure 7. Wearable and Physiological Endpoints Image Figure 8. Voice, Video and Cognitive Endpoints Image Figure 9. Multimodal Endpoints Image Figure 10. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global AI Clinical Endpoint Assessment Software Market Size Share 2021 VS 2025 VS 2032 Figure 12. Oncology Image Figure 13. Neurology and Psychiatry Image Figure 14. Cardiovascular and Metabolic Diseases Image Figure 15. Respiratory Diseases Image Figure 16. Musculoskeletal and Immunology Image Figure 17. Other Therapeutic Areas Image Figure 18. Global AI Clinical Endpoint Assessment Software Market Size (US$ Million) & (2021-2032) Figure 19. Global AI Clinical Endpoint Assessment Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global AI Clinical Endpoint Assessment Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global AI Clinical Endpoint Assessment Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global AI Clinical Endpoint Assessment Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global AI Clinical Endpoint Assessment Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Type (2021-2032) Figure 26. Global AI Clinical Endpoint Assessment Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 28. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2021-2032) Figure 29. North America AI Clinical Endpoint Assessment Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. North America AI Clinical Endpoint Assessment Software Revenue Share by Type (2021-2032) Figure 31. North America AI Clinical Endpoint Assessment Software Revenue Share by Application (2021-2032) Figure 32. North America AI Clinical Endpoint Assessment Software Revenue Share by Country (2021-2032) Figure 33. United States AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Canada AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Mexico AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Europe AI Clinical Endpoint Assessment Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 37. Europe AI Clinical Endpoint Assessment Software Revenue Share by Type (2021-2032) Figure 38. Europe AI Clinical Endpoint Assessment Software Revenue Share by Application (2021-2032) Figure 39. Europe AI Clinical Endpoint Assessment Software Revenue Share by Country (2021-2032) Figure 40. Germany AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. France AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. U.K. AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Italy AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Spain AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Russia AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Netherlands AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Nordic Countries AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. China AI Clinical Endpoint Assessment Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. China AI Clinical Endpoint Assessment Software Revenue Share by Type (2021-2032) Figure 50. China AI Clinical Endpoint Assessment Software Revenue Share by Application (2021-2032) Figure 51. Asia AI Clinical Endpoint Assessment Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 52. Asia AI Clinical Endpoint Assessment Software Revenue Share by Type (2021-2032) Figure 53. Asia AI Clinical Endpoint Assessment Software Revenue Share by Application (2021-2032) Figure 54. Asia AI Clinical Endpoint Assessment Software Revenue Share by Region (2021-2032) Figure 55. Japan AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. South Korea AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. India AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Australia AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Taiwan AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Southeast Asia AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. SAMEA AI Clinical Endpoint Assessment Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 62. SAMEA AI Clinical Endpoint Assessment Software Revenue Share by Type (2021-2032) Figure 63. SAMEA AI Clinical Endpoint Assessment Software Revenue Share by Application (2021-2032) Figure 64. SAMEA AI Clinical Endpoint Assessment Software Revenue Share by Country (2021-2032) Figure 65. Brazil AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Argentina AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Chile AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Colombia AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Peru AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Saudi Arabia AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Israel AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. UAE AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Turkey AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Iran AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Egypt AI Clinical Endpoint Assessment Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Medical Imaging Endpoints
  • Digital Pathology Endpoints
  • Electronic Clinical Outcome Assessment
  • Wearable and Physiological Endpoints
  • Voice, Video and Cognitive Endpoints
  • Multimodal Endpoints
Applications
  • Oncology
  • Neurology and Psychiatry
  • Cardiovascular and Metabolic Diseases
  • Respiratory Diseases
  • Musculoskeletal and Immunology
  • Other Therapeutic Areas
Companies covered
  • IQVIA
  • ICON
  • Perceptive
  • Clinical Ink
  • Koneksa
  • AiCure
  • Medable
  • PathAI
  • Proscia
  • Paige
  • IXICO
  • Median Technologies
  • VIDA Diagnostics
  • Image Analysis Group
  • QMENTA
  • Cambridge Cognition
  • Cogstate
  • Empatica
  • Cumulus Neuroscience
  • Rune Labs
  • VivoSense
  • NeuraLight
  • Aural Analytics
  • Linus Health
  • Quibim
  • Perspectum
  • Brainomix
  • Taimei Technology
  • UnionClin
  • XincereMed
  • Clario
  • Medidata
  • Signant Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Clinical Endpoint Assessment Software Market by Type
  3. 1.2.1 Global AI Clinical Endpoint Assessment Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Medical Imaging Endpoints
  5. 1.2.3 Digital Pathology Endpoints
  6. 1.2.4 Electronic Clinical Outcome Assessment
  7. 1.2.5 Wearable and Physiological Endpoints
  8. 1.2.6 Voice, Video and Cognitive Endpoints
  9. 1.2.7 Multimodal Endpoints
  10. 1.3 AI Clinical Endpoint Assessment Software Market by Application
  11. 1.3.1 Global AI Clinical Endpoint Assessment Software Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Oncology
  13. 1.3.3 Neurology and Psychiatry
  14. 1.3.4 Cardiovascular and Metabolic Diseases
  15. 1.3.5 Respiratory Diseases
  16. 1.3.6 Musculoskeletal and Immunology
  17. 1.3.7 Other Therapeutic Areas
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 AI Clinical Endpoint Assessment Software Market Dynamics
  1. 2.1 AI Clinical Endpoint Assessment Software Industry Trends
  2. 2.2 AI Clinical Endpoint Assessment Software Industry Drivers
  3. 2.3 AI Clinical Endpoint Assessment Software Industry Opportunities and Challenges
  4. 2.4 AI Clinical Endpoint Assessment Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Clinical Endpoint Assessment Software Market Perspective (2021-2032)
  2. 3.2 Global AI Clinical Endpoint Assessment Software Growth Trends by Region
  3. 3.2.1 Global AI Clinical Endpoint Assessment Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Clinical Endpoint Assessment Software Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Clinical Endpoint Assessment Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Clinical Endpoint Assessment Software Revenue by Players
  2. 4.1.1 Global AI Clinical Endpoint Assessment Software Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Clinical Endpoint Assessment Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Clinical Endpoint Assessment Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Clinical Endpoint Assessment Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Clinical Endpoint Assessment Software Key Players Headquarters & Area Served
  7. 4.4 Global AI Clinical Endpoint Assessment Software Players, Product Type & Application
  8. 4.5 Global AI Clinical Endpoint Assessment Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Clinical Endpoint Assessment Software Market CR5 and HHI
  11. 4.6.3 2025 AI Clinical Endpoint Assessment Software Tier 1, Tier 2, and Tier 3
5 AI Clinical Endpoint Assessment Software Market Size by Type
  1. 5.1 Global AI Clinical Endpoint Assessment Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Clinical Endpoint Assessment Software Revenue by Type (2021-2032)
  3. 5.3 Global AI Clinical Endpoint Assessment Software Revenue Market Share by Type (2021-2032)
6 AI Clinical Endpoint Assessment Software Market Size by Application
  1. 6.1 Global AI Clinical Endpoint Assessment Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Clinical Endpoint Assessment Software Revenue by Application (2021-2032)
  3. 6.3 Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 IQVIA
  2. 7.1.1 IQVIA Company Information
  3. 7.1.2 IQVIA Business Overview
  4. 7.1.3 IQVIA AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 IQVIA AI Clinical Endpoint Assessment Software Product Portfolio
  6. 7.1.5 IQVIA Recent Developments
  7. 7.2 ICON
  8. 7.2.1 ICON Company Information
  9. 7.2.2 ICON Business Overview
  10. 7.2.3 ICON AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 ICON AI Clinical Endpoint Assessment Software Product Portfolio
  12. 7.2.5 ICON Recent Developments
  13. 7.3 Perceptive
  14. 7.3.1 Perceptive Company Information
  15. 7.3.2 Perceptive Business Overview
  16. 7.3.3 Perceptive AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Perceptive AI Clinical Endpoint Assessment Software Product Portfolio
  18. 7.3.5 Perceptive Recent Developments
  19. 7.4 Clinical Ink
  20. 7.4.1 Clinical Ink Company Information
  21. 7.4.2 Clinical Ink Business Overview
  22. 7.4.3 Clinical Ink AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Clinical Ink AI Clinical Endpoint Assessment Software Product Portfolio
  24. 7.4.5 Clinical Ink Recent Developments
  25. 7.5 Koneksa
  26. 7.5.1 Koneksa Company Information
  27. 7.5.2 Koneksa Business Overview
  28. 7.5.3 Koneksa AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Koneksa AI Clinical Endpoint Assessment Software Product Portfolio
  30. 7.5.5 Koneksa Recent Developments
  31. 7.6 AiCure
  32. 7.6.1 AiCure Company Information
  33. 7.6.2 AiCure Business Overview
  34. 7.6.3 AiCure AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 AiCure AI Clinical Endpoint Assessment Software Product Portfolio
  36. 7.6.5 AiCure Recent Developments
  37. 7.7 Medable
  38. 7.7.1 Medable Company Information
  39. 7.7.2 Medable Business Overview
  40. 7.7.3 Medable AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Medable AI Clinical Endpoint Assessment Software Product Portfolio
  42. 7.7.5 Medable Recent Developments
  43. 7.8 PathAI
  44. 7.8.1 PathAI Company Information
  45. 7.8.2 PathAI Business Overview
  46. 7.8.3 PathAI AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 PathAI AI Clinical Endpoint Assessment Software Product Portfolio
  48. 7.8.5 PathAI Recent Developments
  49. 7.9 Proscia
  50. 7.9.1 Proscia Company Information
  51. 7.9.2 Proscia Business Overview
  52. 7.9.3 Proscia AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Proscia AI Clinical Endpoint Assessment Software Product Portfolio
  54. 7.9.5 Proscia Recent Developments
  55. 7.10 Paige
  56. 7.10.1 Paige Company Information
  57. 7.10.2 Paige Business Overview
  58. 7.10.3 Paige AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Paige AI Clinical Endpoint Assessment Software Product Portfolio
  60. 7.10.5 Paige Recent Developments
  61. 7.11 IXICO
  62. 7.11.1 IXICO Company Information
  63. 7.11.2 IXICO Business Overview
  64. 7.11.3 IXICO AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 IXICO AI Clinical Endpoint Assessment Software Product Portfolio
  66. 7.11.5 IXICO Recent Developments
  67. 7.12 Median Technologies
  68. 7.12.1 Median Technologies Company Information
  69. 7.12.2 Median Technologies Business Overview
  70. 7.12.3 Median Technologies AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Median Technologies AI Clinical Endpoint Assessment Software Product Portfolio
  72. 7.12.5 Median Technologies Recent Developments
  73. 7.13 VIDA Diagnostics
  74. 7.13.1 VIDA Diagnostics Company Information
  75. 7.13.2 VIDA Diagnostics Business Overview
  76. 7.13.3 VIDA Diagnostics AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 VIDA Diagnostics AI Clinical Endpoint Assessment Software Product Portfolio
  78. 7.13.5 VIDA Diagnostics Recent Developments
  79. 7.14 Image Analysis Group
  80. 7.14.1 Image Analysis Group Company Information
  81. 7.14.2 Image Analysis Group Business Overview
  82. 7.14.3 Image Analysis Group AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Image Analysis Group AI Clinical Endpoint Assessment Software Product Portfolio
  84. 7.14.5 Image Analysis Group Recent Developments
  85. 7.15 QMENTA
  86. 7.15.1 QMENTA Company Information
  87. 7.15.2 QMENTA Business Overview
  88. 7.15.3 QMENTA AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 QMENTA AI Clinical Endpoint Assessment Software Product Portfolio
  90. 7.15.5 QMENTA Recent Developments
  91. 7.16 Cambridge Cognition
  92. 7.16.1 Cambridge Cognition Company Information
  93. 7.16.2 Cambridge Cognition Business Overview
  94. 7.16.3 Cambridge Cognition AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Cambridge Cognition AI Clinical Endpoint Assessment Software Product Portfolio
  96. 7.16.5 Cambridge Cognition Recent Developments
  97. 7.17 Cogstate
  98. 7.17.1 Cogstate Company Information
  99. 7.17.2 Cogstate Business Overview
  100. 7.17.3 Cogstate AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Cogstate AI Clinical Endpoint Assessment Software Product Portfolio
  102. 7.17.5 Cogstate Recent Developments
  103. 7.18 Empatica
  104. 7.18.1 Empatica Company Information
  105. 7.18.2 Empatica Business Overview
  106. 7.18.3 Empatica AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Empatica AI Clinical Endpoint Assessment Software Product Portfolio
  108. 7.18.5 Empatica Recent Developments
  109. 7.19 Cumulus Neuroscience
  110. 7.19.1 Cumulus Neuroscience Company Information
  111. 7.19.2 Cumulus Neuroscience Business Overview
  112. 7.19.3 Cumulus Neuroscience AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Cumulus Neuroscience AI Clinical Endpoint Assessment Software Product Portfolio
  114. 7.19.5 Cumulus Neuroscience Recent Developments
  115. 7.20 Rune Labs
  116. 7.20.1 Rune Labs Company Information
  117. 7.20.2 Rune Labs Business Overview
  118. 7.20.3 Rune Labs AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Rune Labs AI Clinical Endpoint Assessment Software Product Portfolio
  120. 7.20.5 Rune Labs Recent Developments
  121. 7.21 VivoSense
  122. 7.21.1 VivoSense Company Information
  123. 7.21.2 VivoSense Business Overview
  124. 7.21.3 VivoSense AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  125. 7.21.4 VivoSense AI Clinical Endpoint Assessment Software Product Portfolio
  126. 7.21.5 VivoSense Recent Developments
  127. 7.22 NeuraLight
  128. 7.22.1 NeuraLight Company Information
  129. 7.22.2 NeuraLight Business Overview
  130. 7.22.3 NeuraLight AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  131. 7.22.4 NeuraLight AI Clinical Endpoint Assessment Software Product Portfolio
  132. 7.22.5 NeuraLight Recent Developments
  133. 7.23 Aural Analytics
  134. 7.23.1 Aural Analytics Company Information
  135. 7.23.2 Aural Analytics Business Overview
  136. 7.23.3 Aural Analytics AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Aural Analytics AI Clinical Endpoint Assessment Software Product Portfolio
  138. 7.23.5 Aural Analytics Recent Developments
  139. 7.24 Linus Health
  140. 7.24.1 Linus Health Company Information
  141. 7.24.2 Linus Health Business Overview
  142. 7.24.3 Linus Health AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Linus Health AI Clinical Endpoint Assessment Software Product Portfolio
  144. 7.24.5 Linus Health Recent Developments
  145. 7.25 Quibim
  146. 7.25.1 Quibim Company Information
  147. 7.25.2 Quibim Business Overview
  148. 7.25.3 Quibim AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Quibim AI Clinical Endpoint Assessment Software Product Portfolio
  150. 7.25.5 Quibim Recent Developments
  151. 7.26 Perspectum
  152. 7.26.1 Perspectum Company Information
  153. 7.26.2 Perspectum Business Overview
  154. 7.26.3 Perspectum AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Perspectum AI Clinical Endpoint Assessment Software Product Portfolio
  156. 7.26.5 Perspectum Recent Developments
  157. 7.27 Brainomix
  158. 7.27.1 Brainomix Company Information
  159. 7.27.2 Brainomix Business Overview
  160. 7.27.3 Brainomix AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Brainomix AI Clinical Endpoint Assessment Software Product Portfolio
  162. 7.27.5 Brainomix Recent Developments
  163. 7.28 Taimei Technology
  164. 7.28.1 Taimei Technology Company Information
  165. 7.28.2 Taimei Technology Business Overview
  166. 7.28.3 Taimei Technology AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Taimei Technology AI Clinical Endpoint Assessment Software Product Portfolio
  168. 7.28.5 Taimei Technology Recent Developments
  169. 7.29 UnionClin
  170. 7.29.1 UnionClin Company Information
  171. 7.29.2 UnionClin Business Overview
  172. 7.29.3 UnionClin AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  173. 7.29.4 UnionClin AI Clinical Endpoint Assessment Software Product Portfolio
  174. 7.29.5 UnionClin Recent Developments
  175. 7.30 XincereMed
  176. 7.30.1 XincereMed Company Information
  177. 7.30.2 XincereMed Business Overview
  178. 7.30.3 XincereMed AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  179. 7.30.4 XincereMed AI Clinical Endpoint Assessment Software Product Portfolio
  180. 7.30.5 XincereMed Recent Developments
  181. 7.31 Clario
  182. 7.31.1 Clario Company Information
  183. 7.31.2 Clario Business Overview
  184. 7.31.3 Clario AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  185. 7.31.4 Clario AI Clinical Endpoint Assessment Software Product Portfolio
  186. 7.31.5 Clario Recent Developments
  187. 7.32 Medidata
  188. 7.32.1 Medidata Company Information
  189. 7.32.2 Medidata Business Overview
  190. 7.32.3 Medidata AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  191. 7.32.4 Medidata AI Clinical Endpoint Assessment Software Product Portfolio
  192. 7.32.5 Medidata Recent Developments
  193. 7.33 Signant Health
  194. 7.33.1 Signant Health Company Information
  195. 7.33.2 Signant Health Business Overview
  196. 7.33.3 Signant Health AI Clinical Endpoint Assessment Software Revenue and Gross Margin (2021-2026)
  197. 7.33.4 Signant Health AI Clinical Endpoint Assessment Software Product Portfolio
  198. 7.33.5 Signant Health Recent Developments
8 North America
  1. 8.1 North America AI Clinical Endpoint Assessment Software Revenue (2021-2032)
  2. 8.2 North America AI Clinical Endpoint Assessment Software Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Clinical Endpoint Assessment Software Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Clinical Endpoint Assessment Software Revenue by Type (2027-2032)
  5. 8.3 North America AI Clinical Endpoint Assessment Software Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Clinical Endpoint Assessment Software Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Clinical Endpoint Assessment Software Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Clinical Endpoint Assessment Software Revenue by Application (2027-2032)
  9. 8.5 North America AI Clinical Endpoint Assessment Software Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Clinical Endpoint Assessment Software Revenue by Country
  11. 8.6.1 North America AI Clinical Endpoint Assessment Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Clinical Endpoint Assessment Software Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Clinical Endpoint Assessment Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Clinical Endpoint Assessment Software Revenue (2021-2032)
  2. 9.2 Europe AI Clinical Endpoint Assessment Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Clinical Endpoint Assessment Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Clinical Endpoint Assessment Software Revenue by Type (2027-2032)
  5. 9.3 Europe AI Clinical Endpoint Assessment Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Clinical Endpoint Assessment Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Clinical Endpoint Assessment Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Clinical Endpoint Assessment Software Revenue by Application (2027-2032)
  9. 9.5 Europe AI Clinical Endpoint Assessment Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Clinical Endpoint Assessment Software Revenue by Country
  11. 9.6.1 Europe AI Clinical Endpoint Assessment Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Clinical Endpoint Assessment Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Clinical Endpoint Assessment Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Clinical Endpoint Assessment Software Revenue (2021-2032)
  2. 10.2 China AI Clinical Endpoint Assessment Software Revenue by Type (2021-2032)
  3. 10.2.1 China AI Clinical Endpoint Assessment Software Revenue by Type (2021-2026)
  4. 10.2.2 China AI Clinical Endpoint Assessment Software Revenue by Type (2027-2032)
  5. 10.3 China AI Clinical Endpoint Assessment Software Revenue Share by Type (2021-2032)
  6. 10.4 China AI Clinical Endpoint Assessment Software Revenue by Application (2021-2032)
  7. 10.4.1 China AI Clinical Endpoint Assessment Software Revenue by Application (2021-2026)
  8. 10.4.2 China AI Clinical Endpoint Assessment Software Revenue by Application (2027-2032)
  9. 10.5 China AI Clinical Endpoint Assessment Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Clinical Endpoint Assessment Software Revenue (2021-2032)
  2. 11.2 Asia AI Clinical Endpoint Assessment Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Clinical Endpoint Assessment Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Clinical Endpoint Assessment Software Revenue by Type (2027-2032)
  5. 11.3 Asia AI Clinical Endpoint Assessment Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Clinical Endpoint Assessment Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Clinical Endpoint Assessment Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Clinical Endpoint Assessment Software Revenue by Application (2027-2032)
  9. 11.5 Asia AI Clinical Endpoint Assessment Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Clinical Endpoint Assessment Software Revenue by Country
  11. 11.6.1 Asia AI Clinical Endpoint Assessment Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Clinical Endpoint Assessment Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Clinical Endpoint Assessment Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Clinical Endpoint Assessment Software Revenue (2021-2032)
  2. 12.2 SAMEA AI Clinical Endpoint Assessment Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Clinical Endpoint Assessment Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Clinical Endpoint Assessment Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Clinical Endpoint Assessment Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Clinical Endpoint Assessment Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Clinical Endpoint Assessment Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Clinical Endpoint Assessment Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Clinical Endpoint Assessment Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Clinical Endpoint Assessment Software Revenue by Country
  11. 12.6.1 SAMEA AI Clinical Endpoint Assessment Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Clinical Endpoint Assessment Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Clinical Endpoint Assessment Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst